Contraception

Showing 5 posts of 5 posts found.

Levosert® (52mg levonorgestrel intrauterine system [IUS]) receives an 8-year licence extension in the UK for contraception

August 5, 2024
Research and Development Contraception, UK, contraception, license extension

Gedeon Richter UK Ltd. (“Richter”) today announced that the Medicines Health Regulatory Authority (MHRA) has authorised an extension to the …

handshake

Inizio Engage and Nye Health form a strategic alliance to enhance patient support and outcomes 

August 1, 2024
Research and Development Contraception, Inizio Engage, NHS, Nye Health, alliance, data, patient data, patient experience, support

 Nye Health’s digital platform will be coupled with the patient support experience available at Inizio Engage. The integrated approach will …

FDA approves first OTC daily oral contraceptive pill

July 14, 2023
Medical Communications Contraception, FDA, OTC, Opill, contraceptive pill

The US Food and Drug Administration (FDA) has announced that it has approved the Opill (norgestrel) tablet for nonprescription use …

FDA advisory committee votes in favour of OTC contraceptive pill

May 11, 2023
Medical Communications Contraception, FDA, OTC, Perrigo, contraception

Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …

The Gateway to Local Adoption Series

Latest content